Health Care · Biological Products, (No Diagnostic Substances) · NYSE · CIK 1855485 · FYE Dec 31 · Prices AT CLOSE 2026-08-21 (USD) Last $1.34 · Day +0.00% · 1Y −95.1% · Off 52W high −95.5% · Vol (1Y) 93.3% Price2023-09-13 → 2026-08-21 CLDI close: $15,422 on 2023-09-13 to $1 on 2026-08-21. Split-adj closes · 240 of 732 · price returnⓘ At a glance | Short interest5.4% of sh out | | Days to cover1.0d | | 13F net flow (QoQ)+0.95% | | Top-10 13F concentration95.8% | | Next report (est.)2026-11-12 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | Earnings (TTM)-$17.5M | | ROE−752.2% | | Debt / equity0.18× |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD−92.8% | | 1Y−95.1% | | Since incept. (ann.)−95.9% |
Total return · from 2023-09-13ⓘ Risk | Ann. volatility (1Y)93.3% | | Ann. volatility (3Y)160.9% | | Sharpe (1Y)−2.73 | | Sharpe (3Y)−1.18 | | Max drawdown (1Y)−95.4% | | Max drawdown (3Y)−100.0% | | Beta (3Y vs SPY)3.29 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| ARMISTICE CAPITAL, LLC | 879,000 | $209,905 | 8.07% | new | | SABBY MANAGEMENT, LLC | 434,903 | $103,855 | 3.99% | new | | Warberg Asset Management LLC | 250,000 | $59,475 | 2.29% | new | | HighTower Advisors, LLC | 83,523 | $19,945 | 0.77% | +0.0% | | Virtu Financial LLC | 75,769 | $18,000 | 0.70% | +256.7% | | GEODE CAPITAL MANAGEMENT, LLC | 63,019 | $15,048 | 0.58% | +50.3% | | RS CRUM INC. | 40,256 | $9,614 | 0.37% | +98.7% | | Arax Advisory Partners | 37,345 | $8,918 | 0.34% | new |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-13 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-13 | — | — | — | — | | 2026-03-31 | 2026-05-14 | — | — | — | — | | 2025-09-30 | 2025-11-13 | — | — | — | — | | 2025-06-30 | 2025-08-08 | — | — | — | — |
As-reported XBRL · next 2026-11-12 est.ⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
|
